{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:08:32Z","timestamp":1758931712853,"version":"3.44.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"DOI":"10.7759\/cureus.93275","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:01:28Z","timestamp":1758891688000},"source":"Crossref","is-referenced-by-count":0,"title":["Optimal Timing of Oral Anticoagulant Therapy Initiation Post-acute Ischemic Stroke: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Nicholas","family":"Aderinto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lama H","family":"Aljamea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal H","family":"Aljamea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195976","article-title":"An intermodal correlation study among imaging, histology, procedural and clinical parameters in cerebral thrombi retrieved from anterior circulation ischemic stroke patients","volume":"11","author":"Viltu\u017enik R","year":"2022","unstructured":"Viltu\u017enik R, Bajd F, Milo\u0161evi\u010d Z, et al.. An intermodal correlation study among imaging, histology, procedural and clinical parameters in cerebral thrombi retrieved from anterior circulation ischemic stroke patients. J Clin Med. 2022, 11:5976. 10.3390\/jcm11195976","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303048","article-title":"Early versus later anticoagulation for stroke with atrial fibrillation","volume":"388","author":"Fischer U","year":"2023","unstructured":"Fischer U, Koga M, Strbian D, et al.. Early versus later anticoagulation for stroke with atrial fibrillation. N Engl J Med. 2023, 388:2411-21. 10.1056\/NEJMoa2303048","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/17562864221122491","article-title":"Advancement of door-to-needle times in acute stroke treatment after repetitive process analysis: never give up!","volume":"15","author":"Ernst J","year":"2022","unstructured":"Ernst J, Storch KF, Tran AT, et al.. Advancement of door-to-needle times in acute stroke treatment after repetitive process analysis: never give up!. Ther Adv Neurol Disord. 2022, 15:17562864221122491. 10.1177\/17562864221122491","journal-title":"Ther Adv Neurol Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ana.27007","article-title":"Golden hour intravenous thrombolysis for acute ischemic stroke: a systematic review and meta-analysis","volume":"96","author":"Al-Ajlan FS","year":"2024","unstructured":"Al-Ajlan FS, Alkhiri A, Alamri AF, et al.. Golden hour intravenous thrombolysis for acute ischemic stroke: a systematic review and meta-analysis. Ann Neurol. 2024, 96:582-90. 10.1002\/ana.27007","journal-title":"Ann Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25844","article-title":"Anticoagulation timing in cardioembolic stroke and recurrent event risk","volume":"88","author":"Yaghi S","year":"2020","unstructured":"Yaghi S, Trivedi T, Henninger N, et al.. Anticoagulation timing in cardioembolic stroke and recurrent event risk. Ann Neurol. 2020, 88:807-16. 10.1002\/ana.25844","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2023-002727","article-title":"Thrombolysis for ischaemic stroke despite direct oral anticoagulation","volume":"9","author":"Purrucker JC","year":"2024","unstructured":"Purrucker JC, Meinel TR, Wilson D, Xian Y, Wu TY, Seiffge DJ. Thrombolysis for ischaemic stroke despite direct oral anticoagulation. Stroke Vasc Neurol. 2024, 9:464-6. 10.1136\/svn-2023-002727","journal-title":"Stroke Vasc Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/2514183X21999228","article-title":"Acute revascularization in ischemic stroke: updated Swiss guidelines","volume":"5","author":"Michel P","year":"2021","unstructured":"Michel P, Arnold M, De Marchis GM, et al.. Acute revascularization in ischemic stroke: updated Swiss guidelines. Clin Transl Neurosci. 2021, 5:2514183X2199922. 10.1177\/2514183X21999228","journal-title":"Clin Transl Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-020-00877-y","article-title":"Delayed recanalization - how late is not too late?","volume":"12","author":"Kang R","year":"2021","unstructured":"Kang R, Gamdzyk M, Tang H, Luo Y, Lenahan C, Zhang JH. Delayed recanalization - how late is not too late?. Transl Stroke Res. 2021, 12:382-93. 10.1007\/s12975-020-00877-y","journal-title":"Transl Stroke Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/1756286421997368","article-title":"Off-label use of intravenous thrombolysis for acute ischemic stroke: a critical appraisal of randomized and real-world evidence","volume":"14","author":"Tsivgoulis G","year":"2021","unstructured":"Tsivgoulis G, Kargiotis O, De Marchis G, et al.. Off-label use of intravenous thrombolysis for acute ischemic stroke: a critical appraisal of randomized and real-world evidence. Ther Adv Neurol Disord. 2021, 14:1756286421997368. 10.1177\/1756286421997368","journal-title":"Ther Adv Neurol Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02286-2","article-title":"Trends in anticoagulation management services following incorporation of direct oral anticoagulants at a large academic medical center","volume":"51","author":"Mills C","year":"2021","unstructured":"Mills C, Snider MJ, Ortman TC, et al.. Trends in anticoagulation management services following incorporation of direct oral anticoagulants at a large academic medical center. J Thromb Thrombolysis. 2021, 51:1050-8. 10.1007\/s11239-020-02286-2","journal-title":"J Thromb Thrombolysis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000515829","article-title":"Stroke prevention: little-known and neglected aspects","volume":"50","author":"Azarpazhooh MR","year":"2021","unstructured":"Azarpazhooh MR, Bogiatzi C, Spence JD. Stroke prevention: little-known and neglected aspects. Cerebrovasc Dis. 2021, 50:622-35. 10.1159\/000515829","journal-title":"Cerebrovasc Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-023-07012-3","article-title":"New approaches to recovery after stroke","volume":"45","author":"Mar\u00edn-Medina DS","year":"2024","unstructured":"Mar\u00edn-Medina DS, Arenas-Vargas PA, Arias-Botero JC, G\u00f3mez-V\u00e1squez M, Jaramillo-L\u00f3pez MF, Gaspar-Toro JM. New approaches to recovery after stroke. Neurol Sci. 2024, 45:55-63. 10.1007\/s10072-023-07012-3","journal-title":"Neurol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/str.47.suppl_1.tp429","article-title":"Abstract TP429: early oral anticoagulation after acute ischemic stroke in patients with atrial fibrillation","volume":"47","author":"Buletko AB","year":"2016","unstructured":"Buletko AB, Cherian RP, Ahrens C, Uchino K, Russman A. Abstract TP429: early oral anticoagulation after acute ischemic stroke in patients with atrial fibrillation. Stroke. 2016, 47:429. 10.1161\/str.47.suppl_1.tp429","journal-title":"Stroke"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.030042","article-title":"Early apixaban use following stroke in patients with atrial fibrillation: results of the AREST trial","volume":"52","author":"Labovitz AJ","year":"2021","unstructured":"Labovitz AJ, Rose DZ, Fradley MG, et al.. Early apixaban use following stroke in patients with atrial fibrillation: results of the AREST trial. Stroke. 2021, 52:1164-71. 10.1161\/STROKEAHA.120.030042","journal-title":"Stroke"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003283","article-title":"Early start of DOAC after ischemic stroke: risk of intracranial hemorrhage and recurrent events","volume":"87","author":"Seiffge DJ","year":"2016","unstructured":"Seiffge DJ, Traenka C, Polymeris A, et al.. Early start of DOAC after ischemic stroke: risk of intracranial hemorrhage and recurrent events. Neurology. 2016, 87:1856-62. 10.1212\/WNL.0000000000003283","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.060666","article-title":"Early versus delayed non-vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized controlled noninferiority study","volume":"146","author":"Oldgren J","year":"2022","unstructured":"Oldgren J, \u00c5sberg S, Hijazi Z, Wester P, Bertilsson M, Norrving B. Early versus delayed non-vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized controlled noninferiority study. Circulation. 2022, 146:1056-66. 10.1161\/CIRCULATIONAHA.122.060666","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/str.55.suppl_1.66","article-title":"Abstract 66: optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation: primary results of the START trial","volume":"55","author":"Warach SJ","year":"2024","unstructured":"Warach SJ, Davis LA, Lawrence P, et al.. Abstract 66: optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation: primary results of the START trial. Stroke. 2024, 55:66. 10.1161\/str.55.suppl_1.66","journal-title":"Stroke"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105893","article-title":"Anticoagulation protocol for secondary prevention of acute ischemic stroke associated with nonvalvular atrial fibrillation","volume":"30","author":"Kimura T","year":"2021","unstructured":"Kimura T, Tucker A, Nakagaki A, et al.. Anticoagulation protocol for secondary prevention of acute ischemic stroke associated with nonvalvular atrial fibrillation. J Stroke Cerebrovasc Dis. 2021, 30:105893. 10.1016\/j.jstrokecerebrovasdis.2021.105893","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-2313-9","article-title":"Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial","volume":"18","author":"\u00c5sberg S","year":"2017","unstructured":"\u00c5sberg S, Hijazi Z, Norrving B, Ter\u00e9nt A, \u00d6hagen P, Oldgren J. Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial. Trials. 2017, 18:581. 10.1186\/s13063-017-2313-9","journal-title":"Trials"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/str.51.suppl_1.119","article-title":"Abstract 119: initiating oral anticoagulation 4 to 14 days after a cardioembolic stroke is not associated with a reduction in ischemic or hemorrhagic events: the IAC multicenter cohort","volume":"51","author":"Yaghi S","year":"2020","unstructured":"Yaghi S, Giles J, Trivedi T, et al.. Abstract 119: initiating oral anticoagulation 4 to 14 days after a cardioembolic stroke is not associated with a reduction in ischemic or hemorrhagic events: the IAC multicenter cohort. Stroke. 2020, 51:119. 10.1161\/str.51.suppl_1.119","journal-title":"Stroke"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210157","article-title":"Early vs late anticoagulation after ischemic stroke in patients with atrial fibrillation and covert brain infarcts","volume":"104","author":"Kneihsl M","year":"2025","unstructured":"Kneihsl M, Hakim A, Goeldlin MB, et al.. Early vs late anticoagulation after ischemic stroke in patients with atrial fibrillation and covert brain infarcts. Neurology. 2025, 104:e210157. 10.1212\/WNL.0000000000210157","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/ehaa946.2431","article-title":"Safety of early anticoagulation in patients treated with urgent reperfusion for acute ischemic stroke related to non-valvular atrial fibrillation","volume":"21","author":"Giustozzi M","year":"2020","unstructured":"Giustozzi M, Franco L, Reccia A, et al.. Safety of early anticoagulation in patients treated with urgent reperfusion for acute ischemic stroke related to non-valvular atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2020, 21:946-2431. 10.1093\/ehjci\/ehaa946.2431","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-037234","article-title":"Dabigatran initiation in patients with non-valvular AF and first acute ischaemic stroke: a retrospective observational study from the SITS registry","volume":"10","author":"Escudero-Martinez I","year":"2020","unstructured":"Escudero-Martinez I, Mazya M, Teutsch C, et al.. Dabigatran initiation in patients with non-valvular AF and first acute ischaemic stroke: a retrospective observational study from the SITS registry. BMJ Open. 2020, 10:e037234. 10.1136\/bmjopen-2020-037234","journal-title":"BMJ Open"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.645822","article-title":"Protocol for LASER: a randomized evaluation and an associated registry of early anticoagulation with edoxaban after ischemic stroke in patients with atrial fibrillation","volume":"12","author":"Alrohimi A","year":"2021","unstructured":"Alrohimi A, Jickling G, Jeerakathil T, et al.. Protocol for LASER: a randomized evaluation and an associated registry of early anticoagulation with edoxaban after ischemic stroke in patients with atrial fibrillation. Front Neurol. 2021, 12:645822. 10.3389\/fneur.2021.645822","journal-title":"Front Neurol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2020.08.148","article-title":"Effects of timing on in-hospital and one-year outcomes after transcarotid artery revascularization","volume":"73","author":"Cui CL","year":"2021","unstructured":"Cui CL, Dakour-Aridi H, Eldrup-Jorgensen J, Schermerhorn ML, Siracuse JJ, Malas MB. Effects of timing on in-hospital and one-year outcomes after transcarotid artery revascularization. J Vasc Surg. 2021, 73:1649-57.e1. 10.1016\/j.jvs.2020.08.148","journal-title":"J Vasc Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06498-z","article-title":"Predicting reperfusion injury and functional status after stroke using blood biomarkers: the STROKELABED study","volume":"23","author":"Vignoli A","year":"2025","unstructured":"Vignoli A, Sticchi E, Piccardi B, et al.. Predicting reperfusion injury and functional status after stroke using blood biomarkers: the STROKELABED study. J Transl Med. 2025, 23:491. 10.1186\/s12967-025-06498-z","journal-title":"J Transl Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1177\/2396987321989865","article-title":"European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke","volume":"6","author":"Berge E","year":"2021","unstructured":"Berge E, Whiteley W, Audebert H, et al.. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021, 6:I-LXII. 10.1177\/2396987321989865","journal-title":"Eur Stroke J"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.031371","article-title":"Values of baseline posterior circulation acute stroke prognosis early computed tomography score for treatment decision of acute basilar artery occlusion","volume":"52","author":"Sang H","year":"2021","unstructured":"Sang H, Li F, Yuan J, et al.. Values of baseline posterior circulation acute stroke prognosis early computed tomography score for treatment decision of acute basilar artery occlusion. Stroke. 2021, 52:811-20. 10.1161\/STROKEAHA.120.031371","journal-title":"Stroke"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocpiqo.2022.05.009","article-title":"Optimizing door-to-groin puncture time: the Mayo Clinic experience","volume":"6","author":"Rangel I","year":"2022","unstructured":"Rangel I, Palmisciano P, Vanderhye VK, et al.. Optimizing door-to-groin puncture time: the Mayo Clinic experience. Mayo Clin Proc Innov Qual Outcomes. 2022, 6:327-36. 10.1016\/j.mayocpiqo.2022.05.009","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/str.51.suppl_1.tmp18","article-title":"Abstract TMP18: early versus late start of direct oral anticoagulants after an ischemic stroke related to atrial fibrillation - an individual patient data analysis","volume":"51","author":"De Marchis GM","year":"2020","unstructured":"De Marchis GM, Seiffge DJ, Sch\u00e4delin S, et al.. Abstract TMP18: early versus late start of direct oral anticoagulants after an ischemic stroke related to atrial fibrillation - an individual patient data analysis. Stroke. 2020, 51:18. 10.1161\/str.51.suppl_1.tmp18","journal-title":"Stroke"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00975","article-title":"Protocol for AREST: apixaban for early prevention of recurrent embolic stroke and hemorrhagic transformation - a randomized controlled trial of early anticoagulation after acute ischemic stroke in atrial fibrillation","volume":"10","author":"Rose DZ","year":"2019","unstructured":"Rose DZ, Meriwether JN, Fradley MG, et al.. Protocol for AREST: apixaban for early prevention of recurrent embolic stroke and hemorrhagic transformation - a randomized controlled trial of early anticoagulation after acute ischemic stroke in atrial fibrillation. Front Neurol. 2019, 10:975. 10.3389\/fneur.2019.00975","journal-title":"Front Neurol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212354","article-title":"Rivaroxaban administration after acute ischemic stroke: the RELAXED study","volume":"14","author":"Yasaka M","year":"2019","unstructured":"Yasaka M, Minematsu K, Toyoda K, et al.. Rivaroxaban administration after acute ischemic stroke: the RELAXED study. PLoS One. 2019, 14:e0212354. 10.1371\/journal.pone.0212354","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.038239","article-title":"Recurrent ischemic stroke and bleeding in patients with atrial fibrillation who suffered an acute stroke while on treatment with nonvitamin K antagonist oral anticoagulants: the RENO-EXTEND study","volume":"53","author":"Paciaroni M","year":"2022","unstructured":"Paciaroni M, Caso V, Agnelli G, et al.. Recurrent ischemic stroke and bleeding in patients with atrial fibrillation who suffered an acute stroke while on treatment with nonvitamin K antagonist oral anticoagulants: the RENO-EXTEND study. Stroke. 2022, 53:2620-7. 10.1161\/STROKEAHA.121.038239","journal-title":"Stroke"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.4103\/bc.bc_24_20","article-title":"Strokes occurring in the hospital: Symptom recognition and eligibility for treatment in the intensive care units versus hospital wards","volume":"6","author":"Kamal H","year":"2020","unstructured":"Kamal H, Ahmed MK, Zha A, Lail NS, Shirani P, Sawyer RN, Mowla A. Strokes occurring in the hospital: Symptom recognition and eligibility for treatment in the intensive care units versus hospital wards. Brain Circ. 2020, 6:196-9. 10.4103\/bc.bc_24_20","journal-title":"Brain Circ"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11236942","article-title":"Reduction of ischemic stroke-associated disability in the population: a state-wide stroke registry analysis over a decade","volume":"11","author":"Foerch C","year":"2022","unstructured":"Foerch C, Schaller-Paule MA, Steinmetz H, Misselwitz B, Bohmann FO. Reduction of ischemic stroke-associated disability in the population: a state-wide stroke registry analysis over a decade. J Clin Med. 2022, 11:6942. 10.3390\/jcm11236942","journal-title":"J Clin Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-025-08761-6","article-title":"Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): statistical analysis plan for a randomised controlled trial","volume":"26","author":"Ahmed N","year":"2025","unstructured":"Ahmed N, Dehbi HM, Freemantle N, et al.. Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): statistical analysis plan for a randomised controlled trial. Trials. 2025, 26:58. 10.1186\/s13063-025-08761-6","journal-title":"Trials"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007034","article-title":"Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with non-vitamin-K oral anticoagulants (RAF-NOACs) study","volume":"6","author":"Paciaroni M","year":"2017","unstructured":"Paciaroni M, Agnelli G, Falocci N, et al.. Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with non-vitamin-K oral anticoagulants (RAF-NOACs) study. J Am Heart Assoc. 2017, 6:007034. 10.1161\/JAHA.117.007034","journal-title":"J Am Heart Assoc"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1177\/23969873221106043","article-title":"Early versus late initiation of direct oral anticoagulants in post-ischaemic stroke patients with atrial fibrillation (ELAN): protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trial","volume":"7","author":"Fischer U","year":"2022","unstructured":"Fischer U, Trelle S, Branca M, et al.. Early versus late initiation of direct oral anticoagulants in post-ischaemic stroke patients with atrial fibrillation (ELAN): protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trial. Eur Stroke J. 2022, 7:487-95. 10.1177\/23969873221106043","journal-title":"Eur Stroke J"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1177\/17474930211057722","article-title":"Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): protocol for a randomized controlled trial","volume":"17","author":"Best JG","year":"2022","unstructured":"Best JG, Arram L, Ahmed N, et al.. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): protocol for a randomized controlled trial. Int J Stroke. 2022, 17:583-9. 10.1177\/17474930211057722","journal-title":"Int J Stroke"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.069324","article-title":"Early versus late initiation of direct oral anticoagulants after ischemic stroke in people with atrial fibrillation and hemorrhagic transformation: prespecified subanalysis of the randomized-controlled ELAN trial","volume":"150","author":"Rohner R","year":"2024","unstructured":"Rohner R, Kneihsl M, Goeldlin MB, et al.. Early versus late initiation of direct oral anticoagulants after ischemic stroke in people with atrial fibrillation and hemorrhagic transformation: prespecified subanalysis of the randomized-controlled ELAN trial. Circulation. 2024, 150:19-29. 10.1161\/CIRCULATIONAHA.124.069324","journal-title":"Circulation"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2024.1450","article-title":"Early vs late anticoagulation in minor, moderate, and major ischemic stroke with atrial fibrillation: post hoc analysis of the ELAN randomized clinical trial","volume":"81","author":"Goeldlin MB","year":"2024","unstructured":"Goeldlin MB, Hakim A, Branca M, et al.. Early vs late anticoagulation in minor, moderate, and major ischemic stroke with atrial fibrillation: post hoc analysis of the ELAN randomized clinical trial. JAMA Neurol. 2024, 81:693-702. 10.1001\/jamaneurol.2024.1450","journal-title":"JAMA Neurol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.2344\/anpr-70-01-06","article-title":"Perioperative management of oral antithrombotics in dentistry and oral surgery: part 2","volume":"70","author":"Statman BJ","year":"2023","unstructured":"Statman BJ. Perioperative management of oral antithrombotics in dentistry and oral surgery: part 2. Anesth Prog. 2023, 70:37-48. 10.2344\/anpr-70-01-06","journal-title":"Anesth Prog"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.51089","article-title":"Current evidence and expert opinion on thromboprophylaxis after total knee and hip replacement","volume":"15","author":"Mody BS","year":"2023","unstructured":"Mody BS, Wadhwa M, Roy R, Echila S Sr. Current evidence and expert opinion on thromboprophylaxis after total knee and hip replacement. Cureus. 2023, 15:e51089. 10.7759\/cureus.51089","journal-title":"Cureus"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00038-6","article-title":"Risk scores in predicting adverse events following acute coronary syndrome","volume":"397","author":"Templin C","year":"2021","unstructured":"Templin C, Vece DD. Risk scores in predicting adverse events following acute coronary syndrome. Lancet. 2021, 397:172-83. 10.1016\/S0140-6736(21)00038-6","journal-title":"Lancet"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2023.00325","article-title":"Early administration of edoxaban after acute ischemic stroke in patients with non-valvular atrial fibrillation: a pilot randomized trial","volume":"25","author":"Kim JS","year":"2023","unstructured":"Kim JS, Lee KB, Chang DI, Cha JK, Lee JS. Early administration of edoxaban after acute ischemic stroke in patients with non-valvular atrial fibrillation: a pilot randomized trial. J Stroke. 2023, 25:311-14. 10.5853\/jos.2023.00325","journal-title":"J Stroke"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.010383","article-title":"Dabigatran therapy in acute ischemic stroke patients without atrial fibrillation","volume":"46","author":"Kate M","year":"2015","unstructured":"Kate M, Gioia L, Buck B, Sivakumar L, Jeerakathil T, Shuaib A, Butcher K. Dabigatran therapy in acute ischemic stroke patients without atrial fibrillation. Stroke. 2015, 46:2685-7. 10.1161\/STROKEAHA.115.010383","journal-title":"Stroke"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.125.050646","article-title":"Prior reperfusion strategy does not modify outcome in early versus late start of anticoagulants in patients with ischemic stroke: prespecified subanalysis of the randomized controlled ELAN trial","volume":"56","author":"Wouters A","year":"2025","unstructured":"Wouters A, Demeestere J, Rossel JB, et al.. Prior reperfusion strategy does not modify outcome in early versus late start of anticoagulants in patients with ischemic stroke: prespecified subanalysis of the randomized controlled ELAN trial. Stroke. 2025, 56:2000-8. 10.1161\/STROKEAHA.125.050646","journal-title":"Stroke"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2025.0285","article-title":"Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation: a pragmatic, response-adaptive randomized clinical trial","volume":"82","author":"Warach SJ","year":"2025","unstructured":"Warach SJ, Davis LA, Lawrence P, et al.. Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation: a pragmatic, response-adaptive randomized clinical trial. JAMA Neurol. 2025, 82:470-6. 10.1001\/jamaneurol.2025.0285","journal-title":"JAMA Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/416117-optimal-timing-of-oral-anticoagulant-therapy-initiation-post-acute-ischemic-stroke-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:01:29Z","timestamp":1758891689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/416117-optimal-timing-of-oral-anticoagulant-therapy-initiation-post-acute-ischemic-stroke-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.93275","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,26]]}}}